ArticleCureus2026
Longitudinal Response to Epipharyngeal Abrasive Therapy (EAT) in Chronic Nasopharyngitis With Outcome Redefinition and Stratified Analysis by Tissue Type and Baseline Severity.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aimed to evaluate longitudinal changes in nasopharyngeal findings in patients undergoing epipharyngeal abrasive therapy (EAT) and to examine differences in treatment responsiveness according to macroscopic tissue type and baseline severity. In addition, outcome definitions were reconstructed using reproducible criteria based on EAT and bleeding scores, and factors associated with complete resolution were investigated. Methods A total of 546 patients undergoing EAT with nasopharyngeal evaluations from baseline up to 12 months were retrospectively analyzed. Inflammation and bleeding were quantified using EAT and bleeding scores. Longitudinal trends (0-12 months) were assessed using mixed-effects models with Restricted Maximum Likelihood (REML) and Holm correction for multiple comparisons. Primary analyses focused on patients with complete data at 0-3 months (n=238), stratified by macroscopic tissue type (proliferative/hypertrophic vs edematous) and baseline severity (EAT score ≥20 vs <20), using Generalized Estimating Equations (GEE). Complete and incomplete resolutions were compared using Welch's t-test and χ² tests. Results Both EAT and bleeding scores decreased significantly from 1 month onward, with improvements maintained up to 12 months. Stratified analyses suggested differential improvement patterns by tissue type and baseline severity, with edematous tissue and higher baseline scores demonstrating faster initial improvement. Complete resolution (n=76) was associated with lower baseline EAT scores, longer treatment duration, higher number of EAT sessions, and higher prevalence of edematous tissue compared to incomplete resolution (n=470). Redefining outcome criteria increased the number of complete resolution cases from 55 in the previous report to 76. Multivariate logistic regression analysis identified age, tissue type, and baseline severity as independent factors associated with complete resolution. Conclusions EAT leads to early and sustained improvement in inflammation and bleeding in chronic nasopharyngitis. Stratification by tissue type and baseline severity provides clinically relevant insights for predicting treatment response. Outcome re-definition enhances reproducibility and may inform treatment planning and follow-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.